Wednesday, 25 Apr 2018

You are here

Opportunistic Infections in RA Rare with Biologics

The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis (BSRBR) has studied nearly 20,000 patients and observed that there is no substantially different risk of opportunistic infections (OI) between different biologics. 

The primary outcome was any serious OI excluding tuberculosis (TB).

This prospective registry has enrolled 19 282 RA patients with a total of 106 347 years of follow-up.

  • They identified a total of 142 non-TB OI for a rate of 134 cases/100 000 patient years ( or 1.3 OI per 1000 Pt-Yrs)
  • OI rates were not significantly different between the different drug classes
  • Pneumocystis infection was significantly higher with rituximab than with anti-TNF therapy (adjusted hazard ratio = 3.2)
  • TB rates dramatically fell from 783 cases/100 000 pyrs in 2002 to 38 cases/100 000 pyrs in 2015)
  • TB was significantly lower among rituximab users than anti-TNF users, with 12 cases vs. 65 cases per 100 000 pyrs

Overall, patient factors such as age, gender and comorbidity were the most important predictors of OI.

The author has received compensation as an advisor or consultant on this subject

Add new comment

More Like This

Tobacco Associated Deaths in the USA

JAMA Internal Medicine reports that in the USA, those who smoke cigar, pipe, or cigarette have a significant overall  mortality risk, and a much highers cancer mortality risk compared to nonsmokers.

The National Longitudinal Mortality Study collected baseline survey data from 1985 through 2011 and included 357,420 participants reporting on their use of cigar, pipes, or cigarettes.

MMWR: Cannabis Use in the Colorado Workers

MMWR reports that eight states, including Colorado, have legalized recreational marijuana for use by adults and that a study of use in Colorado has shown that nearly 15% of Colorado adult workers have used marijuana in the past 30 days. Use was highest among young adults, especially men, working in the Accommodation/Food Services and Food Preparation/Serving industries.

EMA to Review Methotrexate Overdose and Dosing Errors

A recent meeting (April 9-12) of the European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) considered the problem of dosing errors with methotrexate (MTX), citing "continued reports of overdose." 

2 Weeks Off Methotrexate OK for Flu Vaccine

Stopping methotrexate for 2 weeks after the administration of flu vaccine led to improved immunogenicity without increasing disease activity among patients with rheumatoid arthritis (RA), a prospective Korean study showed.

Risk of Paternal Exposure to Anti-Rheumatic Drugs

Seminars in Arthritis and Rheumatism features a review of the effects of paternal use of antirheumatic drugs on pregnancy, specifically addressing the effects of NSAIDs, steroids, DMARDs and biologics on spermatogenesis and the effect on pregnancy outcomes and offspring.